Why is Tilray stock down today? Cannabis sales decline and key support levels to watch

Traders Union
All News
Stocks
Tilray slides 2.92% today to $3.49

Highlights

Tilray Brands posted record quarterly revenue of $257.1 million for Q1 2026, benefiting from the BrewDog acquisition and growing international distribution.
Core cannabis revenue fell 13% and the company moved to a $40 million net loss due to higher marketing expenses and fuel surcharges.
Shares of Tilray closed at $3.49, down 2.92%, with technical signals showing persistent selling pressure and a projected trading range of $3.31 to $3.67 in the coming days.

Core cannabis weakness and costs offset BrewDog gains and new deals

Tilray Brands reported record first-quarter revenue of $257.1 million for the fiscal quarter ended August 31, 2026, driven by its BrewDog acquisition and strong international cannabis and pharmaceutical distribution yet accompanied by a 13% decline in core cannabis revenue, according to MarketBeat and Panabee. The company swung to a net loss of $40 million from net income of $1.5 million a year earlier, with Gurufocus attributing this shift to increased marketing costs and higher fuel surcharges. Meanwhile, BrewDog reached profitability within the quarter and Tilray entered a multiyear US distribution agreement with Carlsberg Group for European beer brands beginning January 2027, as reported by Aol, but these positive developments were outweighed by the weakness in the primary cannabis segment and deteriorating profitability.

Downward momentum endures as major resistance and volatility converge

On the hourly chart, TLRY is trading below both the MA-20 and MA-50, while remaining well below the MA-200 on the daily chart. The Ichimoku Kijun sits at $3.61, acting as immediate resistance. MACD and ADX are aligned with ongoing selling pressure, while both RSI and CCI are on Sell, signaling continued downward momentum. Stochastic RSI and the Awesome Oscillator are Neutral, indicating some short-term indecision, but Bull/Bear Power points to intermittent buying pressure intraday amid high volatility.

Downside risk prevails as narrow range and key levels define outlook

Over the next two to three trading days, TLRY is expected to fluctuate between $3.31 and $3.67. The probability of an upward move is very low, with a much higher likelihood of further downside, making a price reversal less likely than a continuation of recent losses. If TLRY manages to break above $3.61 (the current Ichimoku Kijun), a short-term rally could follow, while a push below $3.31 would indicate risk of deeper declines. The baseline expectation is for TLRY to remain range-bound, pressured by persistent selling.

Viktoras Karapetjanc, expert at Traders Union, sees Tilray as showing resilience in diversifying its revenue streams, with record quarterly sales led by the BrewDog acquisition. He notes, however, that ongoing weakness in the core cannabis segment and a swing to net loss remain challenges. Despite short-term technical pressure, the analyst believes the company's strategic moves in beverages and new partnerships set a constructive stage for the future. He maintains a moderately optimistic stance based on fundamentals and macro drivers. "If Tilray can stabilize its cannabis business while building on momentum in beverages, I expect sentiment and price action to gradually improve from current lows."

Previously it was reported that Tilray faced persistent technical weakness and elevated downside risks due to ongoing declines in its core cannabis business despite growth in beverage revenues. The latest trading action and mixed quarterly results reinforce this negative technical outlook, with the $3.31 level emerging as a critical support to monitor for potential further declines in the near term.

Source of Data: TLRY Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.